Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease

被引:40
作者
Wang, Ling [1 ]
Wu, Jian [2 ]
Cheng, Jia-Fen [1 ]
Liu, Xin-Ying [1 ]
Ma, Fang [3 ]
Guo, Le-Hang [2 ]
Xu, Jun-Mei [2 ]
Wu, Tianfu [4 ]
Mohan, Chandra [4 ]
Peng, Ai [1 ]
Xu, Hui-Xiong [2 ]
Song, Ya-Xiang [1 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Nephrol & Rheumatol, Shanghai 200072, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Ultrasound Med, Shanghai 200072, Peoples R China
[3] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ultrasound, Shanghai 200030, Peoples R China
[4] Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA
基金
中国国家自然科学基金;
关键词
Contrast-enhanced ultrasound; Renal perfusion; Diabetic kidney disease; GLOMERULAR-FILTRATION-RATE; SERUM URIC-ACID; ENDOTHELIAL DYSFUNCTION; BLOOD-FLOW; PROGRESSION; PERFUSION; INSULIN; ULTRASONOGRAPHY; NEPHROPATHY; PROTEINURIA;
D O I
10.1007/s40620-015-0183-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose To investigate the diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease (DKD). Materials and methods 55 DKD patients with estimated glomerular filtration rate (eGFR) > 30 ml/min/1.73 m(2) and 26 normal controls (NCs) were enrolled. Clinical data was well documented. Blood samples were drawn for evaluation of renal function including blood urea nitrogen (BUN), serum creatinine (SCr) and serum uric acid (SUA), and urine samples were assayed for total protein quantification, and various microprotein markers. According to eGFR level, DKD patients were divided into early-stage DKD (eGFR a parts per thousand yen90 ml/min/1.73 m(2), n = 18) and middle-stage DKD (eGFR 30-90 ml/min/1.73 m(2), n = 37). Based on urinary microalbumin/creatinine ratio (MALB/UCR), early-stage DKD patients were further classified into two groups: MALB/UCR < 10 g/mol (n = 11) and MALB/UCR a parts per thousand yen10 g/mol (n = 7). Then, CEUS was performed to observe the real-time renal perfusion, and low acoustic power contrast-specific imaging was used for quantitative analysis. Results The renal perfusion images of CEUS were well developed successively. The corresponding perfusion curves based on echo-power signals in time series were constructed. Quantitative analysis showed that area under the descending curve (AUC2) was significantly increased in early-stage DKD compared to middle-stage DKD (p < 0.05), but AUC showed no significant difference. Further comparison between different MALB/UCR levels of early-stage DKD showed that patients with MALB/UCR a parts per thousand yen10 g/mol had significantly increased levels of AUC, AUC2 and proteinuria than patients with low MALB/UCR (p < 0.05). Also, high MALB/UCR DKD patients had increased proteinuria but similar eGFR compared to low MALB/UCR patients. Conclusion Renal microvascular hyperperfusion may be responsible for overt proteinuria until decline of renal filtration in DKD. AUC2 could be an early and sensitive marker for early renal injury and renal microvascular hyperperfusion in DKD.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 29 条
[1]   A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease [J].
Agarwal, Rajiv ;
Duffin, Kevin L. ;
Laska, Dennis A. ;
Voelker, James R. ;
Breyer, Matthew D. ;
Mitchell, Peter G. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (12) :2293-2302
[2]   The effects of streptozocin-induced diabetes on renal plasma flow [J].
BaykalErkilic, A ;
Erkilic, M ;
Ozben, T .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1995, 103 (06) :367-372
[3]   A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease [J].
Bhalla, Vivek ;
Velez, Maria-Gabriela ;
Chertow, Glenn M. .
DIABETES, 2013, 62 (01) :31-33
[4]   Monitoring Laparoscopic Radiofrequency Renal Lesions in Real Time Using Contrast-Enhanced Ultrasonography: An Open-Label, Randomized, Comparative Pilot Trial [J].
Chen, Yonghui ;
Huang, Jiwei ;
Xia, Lei ;
Dong, Baijun ;
Chen, Wei ;
Xue, Wei ;
Liu, Dongming ;
Huang, Yiran .
JOURNAL OF ENDOUROLOGY, 2013, 27 (06) :697-704
[5]   Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis [J].
Choi, You-Jin ;
Yoon, Yujin ;
Lee, Kang-Yo ;
Hien, Tran Thi ;
Kang, Keon Wook ;
Kim, Kyong-Cheol ;
Lee, Jeewoo ;
Lee, Moo-Yeol ;
Lee, Seung Mi ;
Kang, Duk-Hee ;
Lee, Byung-Hoon .
FASEB JOURNAL, 2014, 28 (07) :3197-3204
[6]   A Randomized, Controlled, Double- Blind Crossover Study on the Effects of 1-L Infusions of 6% Hydroxyethyl Starch Suspended in 0.9% Saline ( Voluven) and a Balanced Solution ( Plasma Volume Redibag) on Blood Volume, Renal Blood Flow Velocity, and Renal Cortical Tissue Perfusion in Healthy Volunteers [J].
Chowdhury, Abeed H. ;
Cox, Eleanor F. ;
Francis, Susan T. ;
Lobo, Dileep N. .
ANNALS OF SURGERY, 2014, 259 (05) :881-887
[7]   Renal hyperperfusion injury resulting in transient proteinuria post renal artery angioplasty for fibromuscular dysplasia [J].
Heran, Manraj K. S. ;
Sangha, Bippan S. ;
White, Colin .
PEDIATRIC RADIOLOGY, 2012, 42 (04) :491-494
[8]   Glomerular size and glomerulosclerosis: Relationships to disease categories, glomerular solidification, and ischemic obsolescence [J].
Hughson, MD ;
Johnson, K ;
Young, RJ ;
Hoy, WE ;
Bertram, JF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) :679-688
[9]   Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus [J].
Ito, Hiroyuki ;
Abe, Mariko ;
Mifune, Mizuo ;
Oshikiri, Koshiro ;
Antoku, Shinichi ;
Takeuchi, Yuichiro ;
Togane, Michiko .
PLOS ONE, 2011, 6 (11)
[10]   Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney Disease [J].
Kanbay, Mehmet ;
Yilmaz, Mahmut Ilker ;
Sonmez, Alper ;
Turgut, Faruk ;
Saglam, Mutlu ;
Cakir, Erdinc ;
Yenicesu, Mujdat ;
Covic, Adrian ;
Jalal, Diana ;
Johnson, Richard J. .
AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (04) :298-304